RxDoctor Payments Data

John Cooke

Optometrist · Temple, TXNPI 1972510329

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,458 of the $7,359 with a category attached, or 87.8%. Alcon accounts for 62.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $2,073 and has fallen 81.5% since, to $382 in 2025. Among optometrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,359in general payments, 2019–2025

Across 135 payments — averaging $54.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$5K
  • Bausch & Lomb Americas Inc.$902
  • Johnson & Johnson Vision Care, Inc.$791
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$397
  • Coopervision Inc.$200
  • ABB Con-cise Optical Group LLC$158
  • plus $316 from 3 others
$202,966in research payments, 2019–2025

Across 4 payments — averaging $50,742 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Avita Medical Americas, LLC$203K

What the payments were for

  • Travel & lodging$88412%
  • Food & beverage$6,45888%
  • Education$180%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,359 in reported general payments places this provider in the 95th percentile of 4,315 optometrist providers in Texas.

See all optometrist providers in Texas

Medicare billing

Part B allowed, 2024
$34,959
Medicare patients
252
Services billed
368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclosporine16$4,247
Tobramycin-DexamethasoneTobramycin/Dexamethasone12$572

Paid to pharmacies, not to this prescriber.

Other optometrist in Temple

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →